Cancer Epidemiology
Volume 34, Issue 2 , Pages 136-141 , April 2010

Melanocortin 1 receptor (MC1R), pigmentary characteristics and sun exposure: Findings from a case–control study of diffuse large B-cell and follicular lymphoma

  • Eleanor V. Kane

      Affiliations

    • Epidemiology & Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, YO10 5DD, UK
    • ,
  • Dan Painter

      Affiliations

    • Epidemiology & Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, YO10 5DD, UK
    • ,
  • Eve Roman

      Affiliations

    • Epidemiology & Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, YO10 5DD, UK
    • ,
  • James Allan

      Affiliations

    • Department of Biology, University of York, York YO10 5YW, UK
    • ,
  • Graham Law

      Affiliations

    • Division of Biostatistics, Centre of Epidemiology and Biostatistics, Leeds Institute of Genetics, Health and Therapeutics, Worsley Building, University of Leeds, Leeds LS2 9JT, UK
    • ,
  • Tracy Lightfoot

      Affiliations

    • Epidemiology & Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, YO10 5DD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0 190 432 1881; fax: +44 0 190 432 1899.

,Accepted 8 January 2010.

References 

  1. Brennan P, Coates M, Armstrong B, Colin D, Boffetta P. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer. 2000;82(April (7)):1344–1347
  2. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol. 2000;136(May (5)):647–651
  3. Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer. 2001;85(September (7)):997–1005
  4. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer. 2001;91(February (4)):874–880
  5. Hemminki K, Jiang Y, Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies. Markers of impaired immune function?. Eur J Cancer. 2003;39(January (2)):223–229
  6. McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer. 2003;88(January (1)):74–78
  7. Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer. 2005;93(July (1)):159–166
  8. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut, 1935–1988. Cancer. 1992;70(August (4)):840–849
  9. Newton R, Roman E, Fear N, Carpenter L. Non-Hodgkin's lymphoma and solar ultraviolet radiation. Data are inconsistent. BMJ. 1996;313(August (7052)):298
  10. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology. 2001;12(September (5)):552–557
  11. van Wijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med. 2001;43(June (6)):548–553
  12. Tavani A, Bosetti C, Franceschi S, Talamini R, Negri E, La VC. Occupational exposure to ultraviolet radiation and risk of non-Hodgkin lymphoma. Eur J Cancer Prev. 2006;15(October (5)):453–457
  13. Zhang Y, Holford TR, Leaderer B, Boyle P, Zhu Y, Wang R, et al. Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol. 2007;(February):
  14. Grandin L, Orsi L, Troussard X, Monnereau A, Berthou C, Fenaux P, et al. UV radiation exposure, skin type and lymphoid malignancies: results of a French case–control study. Cancer Causes Control. 2008;19(April (3)):305–315
  15. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case–control study. BMJ. 1997;314(May (7092)):1451–1455
  16. Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer. 1999;80(March (5)):641–645
  17. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case–control study. Int J Cancer. 2004;112(December (5)):865–871
  18. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97(February (3)):199–209
  19. Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, et al. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2006;17(October (8)):1045–1052
  20. Weihkopf T, Becker N, Nieters A, Mester B, Deeg E, Elsner G, et al. Sun exposure and malignant lymphoma: a population-based case–control study in Germany. Int J Cancer. 2007;(February):
  21. Soni LK, Hou L, Gapstur SM, Evens AM, Weisenburger DD, Chiu BC. Sun exposure and non-Hodgkin lymphoma: a population-based, case–control study. Eur J Cancer. 2007;43(November (16)):2388–2395
  22. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008;122(January (1)):144–154
  23. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet. 1996;5(October (10)):1663–1666
  24. Meyle KD, Guldberg P. Genetic risk factors for melanoma. Hum Genet. 2009;126(October (4)):499–510
  25. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 1995;11(November (3)):328–330
  26. Flanagan N, Healy E, Ray A, Philips S, Todd C, Jackson IJ, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet. 2000;9(October (17)):2531–2537
  27. Healy E, Flannagan N, Ray A, Todd C, Jackson IJ, Matthews JN, et al. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet. 2000;355(March (9209)):1072–1073
  28. Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet. 2005;14(August (15)):2145–2154
  29. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, Fritschi L, et al. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer. 2004;110(June (3)):429–434
  30. Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A, et al. The descriptive epidemiology of hematological neoplasms: a population-based analysis from the Haematological Malignancy Research Network (HMRN) Br J Haematol 2009 epub ahead of print (submitted for publication).
  31. Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control. 2004;15(October (8)):771–780
  32. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of disease for oncology. 3ed ed.. Geneva: World Health Organisation; 2001;
  33. Sturm RA, Teasdale RD, Box NF. Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene. 2001;277(October (1–2)):49–62
  34. Breslow NE, Day NE. Statistical methods in cancer research. Volume I—the analysis of case–control studies. IARC Sci Publ. 1980;(32):5–338
  35. Intercooled Stata 9.2 for Windows [computer program] . College Station. Texas: STATA Corporation; 2007;
  36. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat. 2007;28(May (5)):495–505
  37. Melia J, Bulman A. Sunburn and tanning in a British population. J Public Health Med. 1995;17(June (2)):223–229
  38. Davies TW, Treasure FP, Welch AA, Day NE. Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. Br J Dermatol. 2002;146(June (6)):1017–1022
  39. Glass D, Lens M, Swaminathan R, Spector TD, Bataille V. Pigmentation and vitamin D metabolism in Caucasians: low vitamin D serum levels in fair skin types in the UK. PLoS One. 2009;4(8):e6477
  40. Parra EJ. Human pigmentation variation: evolution, genetic basis, and implications for public health. Am J Phys Anthropol. 2007;(Suppl. 45):85–105
  41. Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008;4(May (5)):e1000074
  42. Branicki W, Brudnik U, Wojas-Pelc A. Interactions between HERC2, OCA2 and MC1R may influence human pigmentation phenotype. Ann Hum Genet. 2009;73(March (2)):160–170
  43. Gathany AH, Hartge P, Davis S, Cerhan JR, Severson RK, Cozen W, et al. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control. 2009;(April):

PII: S1877-7821(10)00008-1

doi: 10.1016/j.canep.2010.01.005

Cancer Epidemiology
Volume 34, Issue 2 , Pages 136-141 , April 2010

Article Tools